Ticker HubNasdaq

ELUT

Elutia Inc. Class A Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest price

$0.7980-4.72%

As of Oct 26, 2026, 4:00 PM EDT · Market data by Massive

Market cap

$37.1M

Volume

131K

Previous close

$0.8375

Day range

$0.7676 – $0.8689

Listed

Oct 8, 2020

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $0.8050Latest interval $0.8100

Newsroom

Latest ELUT coverage

CompanyDeep DiveSep 16, 2025

Elutia’s Game-Changing Tech Has Boston Scientific’s Full Attention— Is A Bigger Deal Coming Next?

Elutia sells EluPro & CanGaroo assets to Boston Scientific for $88M, erasing debt and funding NXT-41—sparking speculation this divestiture could set the stage for a future full-company acquisition.

ELUTBSX

Company overview

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 26
Headquarters: SILVER SPRING, MD
CIK: 0001708527

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Oct 8, 2020

Listed

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.